Business Description
![XBiotech Inc XBiotech Inc logo](https://static.gurufocus.com/logos/0C0000AULR.png?14)
XBiotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA98400H1029
Description
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 20.1 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.25 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -31.2 | |||||
3-Year EPS without NRI Growth Rate | -23.2 | |||||
3-Year FCF Growth Rate | 34.5 | |||||
3-Year Book Growth Rate | -15.5 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.63 | |||||
9-Day RSI | 51.62 | |||||
14-Day RSI | 46.22 | |||||
6-1 Month Momentum % | 75.53 | |||||
12-1 Month Momentum % | 22.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.03 | |||||
Quick Ratio | 12.03 | |||||
Cash Ratio | 11.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -0.03 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -13.76 | |||||
ROA % | -13.24 | |||||
ROIC % | -151.7 | |||||
ROC (Joel Greenblatt) % | -163.1 | |||||
ROCE % | -18.32 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 5.82 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.84 | |||||
EV-to-EBIT | 0.36 | |||||
EV-to-EBITDA | 0.37 | |||||
EV-to-FCF | 0.68 | |||||
Price-to-Projected-FCF | 3.9 | |||||
Price-to-Net-Current-Asset-Value | 0.95 | |||||
Price-to-Net-Cash | 0.97 | |||||
Earnings Yield (Greenblatt) % | 277.78 | |||||
FCF Yield % | -12.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
XBiotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.944 | ||
Beta | 0.17 | ||
Volatility % | 75.71 | ||
14-Day RSI | 46.22 | ||
14-Day ATR (€) | 0.323301 | ||
20-Day SMA (€) | 5.278 | ||
12-1 Month Momentum % | 22.22 | ||
52-Week Range (€) | 3.18 - 9.1 | ||
Shares Outstanding (Mil) | 30.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
XBiotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
XBiotech Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
XBiotech Inc Frequently Asked Questions
What is XBiotech Inc(STU:4XB)'s stock price today?
The current price of STU:4XB is €5.20. The 52 week high of STU:4XB is €9.10 and 52 week low is €3.18.
When is next earnings date of XBiotech Inc(STU:4XB)?
The next earnings date of XBiotech Inc(STU:4XB) is 2024-08-09 Est..
Does XBiotech Inc(STU:4XB) pay dividends? If so, how much?
XBiotech Inc(STU:4XB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |